Search for a command to run...
GPT Healthcare Ltd. exhibits strong profitability metrics with a high ROE of 33.06% and a reasonable debt level, making it a solid player within its peer group. However, its growth metrics show a stagnation in revenue growth YoY, indicating potential challenges ahead. The sector has a mix of strong performers and some financially weak firms, suggesting a cautious approach for investors.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
GPTHEALTH | ₹148.25 | ₹1,216.46Cr | 24.37 | 25.56% | 0.60 |
MAXHEALTH | ₹1,179.65 | ₹1,14,679.30Cr | 163.58 | 16.26% | 0.14 |
APOLLOHOSP | ₹7,676.95 | ₹1,10,383.03Cr | 85.15 | 21.19% | 0.67 |
FORTIS | ₹924.85 | ₹69,822.29Cr | 1094.63 | 12.01% | 0.11 |
MEDANTA | ₹1,395.25 | ₹37,474.60Cr | 81.26 | 20.50% | 0.10 |
NH | ₹1,784.05 | ₹36,459.02Cr | 84.56 | 21.62% | 0.61 |
ASTERDM | ₹605.10 | ₹30,225.53Cr | 5.05 | 11.46% | 0.19 |